Headlines

Madrigal Pharmaceuticals Announces $35 Million Private Placement Offering
June 21, 2017

Madrigal reports that, following a prescheduled DSMB meeting to review data from Madrigal’s Phase 2 NASH clinical trial, the DSMB recognized Madrigal for progress on the clinical trial and recommended continuing the clinical trial with no changes to the protocol
June 15, 2017

Madrigal Pharmaceuticals Reports 2017 First Quarter Financial Results
May 11, 2017

Press Release History